Una candidatura completa en un minuto
Currículum y carta de presentación personalizados, listos para enviar.
Dana-Farber Cancer Institute in Boston is seeking an exceptionally motivated Scientist II to join the Belfer Center teams. The group concentrates on CAR T cell immunotherapy and protein engineering, progressing projects from conception to transgene design and in vivo studies, with a direct path toward the clinic.
You will lead target identification and validation for immune effector cell programs, work on CRISPR/Cas9 knockout/knock-in, vector manufacture, and collaborate across disciplines to
Located in Boston and the surrounding communities, Dana-Farber Cancer Institute is a leader in life changing breakthroughs in cancer research and patient care. We are united in our mission of conquering cancer, HIV/AIDS, and related diseases. We strive to create an inclusive, diverse, and equitable environment where we provide compassionate and comprehensive care to patients of all backgrounds, and design programs to promote public health particularly among high-risk and underserved populations. We conduct groundbreaking research that advances treatment, we educate tomorrow's physician/researchers, and we work with amazing partners, including other Harvard Medical School-affiliated hospitals.
Pre-clinical group developing next generation immune effector cellular therapies for cancer is looking for an exceptionally motivated Scientist II to join the team. The position is funded and directly supervised by Dr. Elliott Brea and sits officially within the Belfer Center for Applied Sciences, Barbie Lab and Smith Lab at Dana-Farber Cancer Institute. The group is focused on CAR T cell immunotherapy for cancer and on protein engineering/synthetic biology; taking projects from conception to transgene design/genetic engineering, through reduction to practice, and into in vivo studies, and ultimately to the clinic. The successful candidate will make substantial contributions to advancing our CAR T and TCE programs to the clinic — with a particular focus on TROP2-directed immune effector cell therapy against drug-tolerant persister (DTP) populations in EGFR-mutant non-small cell lung cancer, including CNS/leptomeningeal disease and direct in vivo administration approaches for our candidates.
None
None
At Dana-Farber Cancer Institute, we work every day to create an innovative, caring, and inclusiveenvironment where every patient, family, and staff member feels they belong. As relentless as we are in our mission to reduce the burden of cancer for all, we are committed to having faculty and staff who offer multifaceted experiences. Cancer knows no boundaries and when it comes to hiring the most dedicated and compassionateprofessionals, neither do we. If working in this kind of organization inspires you, we encourage you to apply.
Dana-Farber Cancer Institute is an equal opportunity employer and affirms the right of every qualified applicant to receive consideration for employment without regard to race, color, religion, sex, gender identity or expression, national origin, sexual orientation, genetic information, disability, age, ancestry, military service, protected veteran status, or other characteristics protected by law.
Pay Transparency Statement
The hiring range is based on market pay structures, with individual salaries determined by factors such as business needs, market conditions, internal equity, and based on the candidate’s relevant experience, skills and qualifications.
For union positions, the pay range is determined by the Collective Bargaining Agreement (CBA).
$85,000.00 - $104,650.00